Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -9.755M
March 31, 2026 -8.992M
December 31, 2025 8.411M
September 30, 2025 16.59M
June 30, 2025 -0.803M
March 31, 2025 19.67M
December 31, 2024 -17.78M
September 30, 2024 2.951M
June 30, 2024 -2.746M
March 31, 2024 -4.628M
December 31, 2023 8.696M
September 30, 2023 -1.208M
June 30, 2023 4.566M
March 31, 2023 -8.214M
December 31, 2022 -3.712M
September 30, 2022 -0.41M
June 30, 2022 4.86M
March 31, 2022 0.967M
December 31, 2021 -1.49M
September 30, 2021 -2.076M
June 30, 2021 5.44M
March 31, 2021 3.208M
December 31, 2020 -0.566M
September 30, 2020 2.667M
June 30, 2020 -2.651M
Date Value
March 31, 2020 -0.55M
December 31, 2019 1.652M
September 30, 2019 -0.07M
June 30, 2019 0.844M
March 31, 2019 -1.476M
December 31, 2018 -0.036M
September 30, 2018 0.323M
June 30, 2018 1.365M
March 31, 2018 -0.965M
December 31, 2017 -0.294M
September 30, 2017 -2.224M
June 30, 2017 -2.305M
March 31, 2017 -3.98M
December 31, 2016 -2.238M
September 30, 2016 -3.909M
June 30, 2016 -2.767M
March 31, 2016 -2.301M
December 31, 2015 -3.301M
September 30, 2015 -2.395M
June 30, 2015 -3.172M
March 31, 2015 -2.275M
December 31, 2014 -2.051M
September 30, 2014 -1.795M
June 30, 2014 -1.532M
March 31, 2014 -1.676M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 381.80M
60 Degrees Pharmaceuticals, Inc. -2.232M
ANI Pharmaceuticals, Inc. 56.67M
Corcept Therapeutics, Inc. 33.54M
Veru, Inc. -5.467M